A Study to Assess the Effect of Fluvoxamine and Smoking on Pharmacokinetics ( the Movement of Drugs Within the Body) of AZD4635 in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Stratified Treatment to Ameliorate Diastolic Left Ventricular Stiffness in Heart Failure With Preserved Ejection Fraction
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Durvalumab or Durvalumab Plus Chemotherapy in Kras Mutation Positive and PD-L1 High (≥ 50%) NSCLC Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
Study to Assess the Pharmacokinetics and Safety of AZD9977 in Participants With Renal Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Hyperkalemia's Illness and Treatment Burden in Chronic Kidney Disease and Heart Failure Patients: HK Registry Pilot Study
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of CRT, Durvalumab and Surgery for SST
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Study of Adavosertib(AZD1775) in Japanese Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Evaluate the Safety of Linaclotide in IBS-C Patients in China
- Status
- COMPLETED
- Phase
- N/A
Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
An INternational Frontline Ovarian Cancer Real World Management Study
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)
- Status
- COMPLETED
- Phase
- PHASE3
Asthma Control in a Dutch Primary Care Population
- Status
- COMPLETED
- Phase
- N/A
Durvalumab Plus Chemotherapy in ES-SCLC (Oriental)
- Status
- COMPLETED
- Phase
- PHASE3
Multiple Ascending Dose Study of MEDI1341 in Patients With Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE1
To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus Patients
- Status
- COMPLETED
- Phase
- PHASE4
Chemoradiation Followed by Durvalumab in Poor Risk and/or Elderly Patients With Stage III NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
National Survey on Care Pathway and Quality of Life in Patients With Severe Asthma According to Their Phenotype.
- Status
- UNKNOWN
- Phase
- N/A
A Study of Acalabrutinib Suspension to Evaluate Relative Bioavailability and Proton-pump Inhibitor Effect in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Immune Checkpoint Inhibitors and Atherosclerotic Plaque Volume
- Status
- COMPLETED
- Phase
- N/A
Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2